Insulin aspart, recombinant Subcutaneous and Sargramostim Solution for Injection
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Sargramostim Solution for Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: sargramostim
Brand name: Leukine
Synonyms: Sargramostim
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Sarilumab
- Insulin aspart, recombinant Subcutaneous-Sarilumab Prefilled Pens
- Insulin aspart, recombinant Subcutaneous-Sarilumab Prefilled Syringes
- Insulin aspart, recombinant Subcutaneous-Sarilumab Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Sarna Hc Topical application
- Insulin aspart, recombinant Subcutaneous-Sarnol-HC
- Sargramostim Solution for Injection-Insulin degludec
- Sargramostim Solution for Injection-Insulin Degludec (U-100) Prefilled Pens
- Sargramostim Solution for Injection-Insulin Degludec (U-100) Vials
- Sargramostim Solution for Injection-Insulin Degludec (U-200) Prefilled Pens
- Sargramostim Solution for Injection-Insulin degludec and liraglutide
- Sargramostim Solution for Injection-Insulin degludec and liraglutide Subcutaneous